Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cross Dehydrogenative Coupling (CDC). These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109651344A reveals a green CuBr-catalyzed method for triarylmethane compounds, offering significant cost reduction in fine chemical manufacturing and high-purity outcomes.
Patent CN106316920B reveals a copper-catalyzed cross-dehydrogenative coupling route for indole glycine derivatives, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN111423405A details a novel Pd-catalyzed cross-dehydrogenative coupling route for benzopyran-3-ol derivatives, offering high yield and mild conditions for pharmaceutical intermediates.
Patent CN111606894A reveals mild Ag-catalyzed C-H activation for ether alpha-position, offering cost-effective routes for drug synthesis.
Patent CN108948077B details a green cobalt-catalyzed synthesis of alpha-phosphorylated amino acid esters using air oxidation, offering significant cost and supply chain advantages for pharmaceutical manufacturers.
Patent CN109651344B reveals a copper-catalyzed green route for triarylmethanes. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN111041515B reveals a metal-free electrochemical route for high-purity quinoxalinone intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN109438402B discloses a green catalytic route for benzofuranone derivatives. High yield, low cost, scalable process ideal for pharmaceutical intermediates manufacturing.